Published in

Wiley, European Journal of Heart Failure, 1(14), p. 14-21, 2012

DOI: 10.1093/eurjhf/hfr146

Links

Tools

Export citation

Search in Google Scholar

Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure.

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Aims Recent studies indicate that brain natriuretic peptide (BNP 1-32) may be truncated into BNP 3-32 by dipeptidyl peptidase IV (DPP4) and that BNP 3-32 has reduced biological activities compared with BNP 1-32. We investigated if DPP4 contributes to the cardiorenal alterations and to the attenuated response to BNP seen in heart failure. Methods and results Haemodynamic and renal assessment was performed in 12 pigs at baseline, 4 weeks after pacing-induced heart failure, and during BNP infusion. They were randomized to either placebo or treatment with a DPP4 inhibitor, sitagliptin. After 4 weeks of pacing, heart rate was reduced compared with baseline in the sitagliptin group (60 ± 2 vs. 95 ± 16 b.p.m. P